Loading data for BWAY — first visit, this takes a few seconds.

BrainsWay Ltd.

NasdaqGM: BWAY · Real-Time Price · USD
14.30
-0.13 (-0.90%)
At close: Aug 26, 2026, 8:00 PM
14.30
+0.00%
After-hours: 7:30 PM

The price, the headline numbers and the latest news, in one place.

BrainsWay Ltd. (BWAY) Stock Price, Analysis & Data

-0.90%

No data available

Bid10.99
Market Cap574.7M
Revenue (ttm)60.7M
Net Income (ttm)9.44M
0.10
0.23
62.17
29.38
P/B (ttm)6.99
P/S (ttm)9.47
Earnings DateNov 15, 2023
Ask19.71
Volume74,211
Avg. Volume (20D)121,646
Open14.59
Previous Close14.43
Day's Range14.02 - 14.59
52-Week Range7.13 - 17.40
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About BWAY

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic...

Sector Healthcare
IPO Date Apr 17, 2019
Employees 129
Stock Exchange NasdaqGM
Ticker Symbol BWAY
Full Company Profile

Financial Performance

In 2025, BrainsWay's revenue was 52.23M, an increase of 27.33% compared to the previous year's 41.02M. Earnings were 7.63M, an increase of 161.31%.

Financial Statements

Earnings Surprise

BrainsWay has released their quarterly earnings on Aug 12, 2026:
  • Revenue of $15.53M misses estimates by $0, with 34.63% YoY growth.
  • EPS of 0.07 misses estimates by 0.00, with 133.33% YoY growth.
BrainsWay Ltd. is scheduled to release its earnings on Nov 15, 2023, before market opens.
Analysts project revenue of ... Upgrade